Completed PHASE3 INTERVENTIONAL 3-arm NCT05950841

Safety and Effectiveness of IHAT in Iron Deficient Pre-menopausal Woman

A Randomised, Double-blind Study to Determine the Safety and Efficacy of IHAT in Iron Deficient Premenopausal Women.

Sponsor: Nemysis Ltd

Interventions Carob flour High Dose IHAT Low dose IHAT

Updated 8 times since 2023 Last updated: Mar 6, 2025 Started: Mar 6, 2024 Primary completion: Feb 3, 2025 Completion: Feb 3, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05950841, this PHASE3 trial focuses on Iron-deficiency and remains completed. Sponsored by Nemysis Ltd, it has been updated 8 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Apr 2025 — Present [monthly]

Completed PHASE3

Status: Recruiting → Completed
Jan 2025 — Apr 2025 [monthly]

Recruiting PHASE3

Status: Not Yet Recruiting → Recruiting
Sep 2024 — Jan 2025 [monthly]

Not Yet Recruiting PHASE3
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting PHASE3
Feb 2024 — Jul 2024 [monthly]

Not Yet Recruiting PHASE3

▶ Show 3 earlier versions

Jan 2024 — Feb 2024 [monthly]

Not Yet Recruiting PHASE3
Nov 2023 — Jan 2024 [monthly]

Not Yet Recruiting PHASE3
Aug 2023 — Nov 2023 [monthly]

Not Yet Recruiting PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Nemysis Ltd
RDC Clinical Pty Ltd

Data source: RDC Clinical Pty Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New Farm, Australia